PulseCath Achieves MDR CE Certification for iVAC 2L

We proudly announce the successful achievement of the transition from Medical Device Directive (MDD) CE marking to Medical Device Regulation (EU) 2017/745 (MDR) for our groundbreaking product, iVAC 2L.
The MDR CE certification signifies PulseCath’s commitment to the highest standards of quality and safety in medical devices. This achievement marks a significant milestone for PulseCath and underscores our commitment to delivering innovative solutions that meet the highest regulatory standards. iVAC 2L represents a leap forward in complex High-Risk PCI’s, and we are eager to make this transformative device available to healthcare providers and patients worldwide.
Please follow this link for the official press release.

Case-in-a-box congress - video 7

Case-in-a-box congress - video 6

Case-in-a-box congress - video 5

Case-in-a-box congress - video 4

Case-in-a-box congress - video 3

Case-in-a-box congress - video 2

Case-in-a-box congress - video 1

Case-in-a-box number 2: Al Qassimi Hospital February 2023

Case-in-a-box number 1: Al Qassimi Hospital February 2023

iVAC 2L Procedure Steps

iVAC 2L Setup

iVAC 2L Trouble Shooting

iVAC 2L Clinical Effect

Complete webinar

PulseCath Achieves MDR CE Certification for iVAC 2L